625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster III

Role of race in severity and survival of those with cutaneous T cell lymphoma

Persistent racial disparities in Sezary syndrome outcomes despite use of modern therapies A single center analysis

Artificial intelligence AI –based membrane specific PD L1 and immune subtypes as predictive biomarkers for danburstotug in relapsed or refractory extranodal NK T cell lymphoma R R ENKTL Insights from the Phase II trial DISTINKT

Brentuximab vedotin plus DHAP as effective salvage therapy in CD30 peripheral T cell lymphoma A retrospective multicenter study

Combination of mitoxantrone hydrochloride liposome with gemcitabine cisplatin and dexamethasone MGDP in patients with relapsed or refractory peripheral T cell lymphoma A prospective single arm multicenter Phase I II study

Peripheral T cell lymphomas Real world insights into clinical features and prognosis

Disaggregating aggressive ATLL A retrospective Study focused on the lymphomatous variant in Latin America

Outcomes of primary cutaneous anaplastic large cell lymphoma across u S cancer care settings A national cancer database analysis

Final results from the embolden trial  pembrolizumab in combination with decitabine and pralatrexate in heavily pretreated patients with peripheral and cutaneous T cell lymphoma

High HDAC I IIb selective inhibitor purinostat mesylate in relapsed and refractory peripheral T cell lymphoma A single agent phase IIa study

Molecular determinants of therapeutic response to nivolumab in Relapsed Refractory PTCL An integrated multiomic study of A phase II investigator initiated trial

Clinical disparities in enteropathy associated T cell lymphoma A national cancer database study of 736 patients treated at academic and community cancer centers

Outcomes of second line systemic therapy for relapsed or refractory peripheral T cell lymphomas A single center retrospective analysis

Determinants of survival in primary cutaneous anaplastic large cell lymphoma pcALCL Analysis of a real world pooled database

Impact of DUSP22 and TP63 rearrangements in patients with ALK negative ALCL treated with frontline BV CH E P

Outcomes of patients with dual primary T cell and B cell lymphoid malignancies